Search by Drug Name or NDC
NDC 64980-0307-60 DentaGel 1.1 g/100g Details
DentaGel 1.1 g/100g
DentaGel is a ORAL GEL in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Rising Pharmaceuticals, Inc.. The primary component is SODIUM FLUORIDE.
MedlinePlus Drug Summary
Fluoride is used to prevent tooth decay. It is taken up by teeth and helps to strengthen teeth, resist acid, and block the cavity-forming action of bacteria. Fluoride usually is prescribed for children and adults whose homes have water that is not fluoridated (already has fluoride added). This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Related Packages: 64980-0307-60Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Fluoride
Product Information
| NDC | 64980-0307 |
|---|---|
| Product ID | 64980-307_d4b7e0f1-72ec-4b12-8d75-4b55656390e1 |
| Associated GPIs | 88402020004020 |
| GCN Sequence Number | 002607 |
| GCN Sequence Number Description | fluoride (sodium) GEL (GRAM) 1.1 % DENTAL |
| HIC3 | D2A |
| HIC3 Description | FLUORIDE PREPARATIONS |
| GCN | 07358 |
| HICL Sequence Number | 001127 |
| HICL Sequence Number Description | FLUORIDE (SODIUM) |
| Brand/Generic | Generic |
| Proprietary Name | DentaGel |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Sodium fluoride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | GEL |
| Route | ORAL |
| Active Ingredient Strength | 1.1 |
| Active Ingredient Units | g/100g |
| Substance Name | SODIUM FLUORIDE |
| Labeler Name | Rising Pharmaceuticals, Inc. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Application Number | n/a |
| Listing Certified Through | 2024-12-31 |
Package
Package Images
NDC 64980-0307-60 (64980030760)
| NDC Package Code | 64980-307-60 |
|---|---|
| Billing NDC | 64980030760 |
| Package | 56 g in 1 TUBE (64980-307-60) |
| Marketing Start Date | 2012-05-01 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.13416 |
| Pricing Unit | GM |
| Effective Date | 2024-02-21 |
| NDC Description | DENTAGEL 1.1% GEL |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
Standard Product Labeling (SPL)/Prescribing Information SPL 944faa31-3f0e-42cd-aa5f-22cd8ed1c131 Details
DESCRIPTION:
Inactive Ingredients:
CLINICAL PHARMACOLOGY:
INDICATIONS AND USAGE:
A dental caries preventive; for once daily self-applied topical use. It is well established that 1.1% sodium fluoride is safe and extraordinarily effective as a caries preventive when applied frequently with mouthpiece applicators.1-4 DentaGel 1.1% Brush-On Gel in a squeeze-tube is easily applied onto a toothbrush as well as a mouthpiece tray. This prescription dental gel should be used once daily following use of a regular toothpaste unless otherwise instructed by your dental professional. May be used whether or not drinking water is fluoridated, since topical fluoride cannot produce fluorosis. (See WARNINGS for exception.)
CONTRAINDICATIONS:
WARNINGS:
Prolonged daily ingestion may result in various degrees of dental fluorosis in pediatric patients under age 6 years, especially if the water fluoridation exceeds 0.6 ppm, since younger pediatric patients frequently cannot perform the brushing process without significant swallowing. Use in pediatric patients under age 6 years requires special supervision to prevent repeated swallowing of gel, which could cause dental fluorosis. Read directions carefully before using. Keep out of reach of infants and children.
PRECAUTIONS:
Not for systemic treatment. DO NOT SWALLOW.
Carcinogenesis, Mutagenesis, Impairment of Fertility:
In a study conducted in rodents, no carcinogenesis was found in male and female mice and female rats treated with fluoride at dose levels ranging from 4.1 to 9.1 mg/kg of body weight. Equivocal evidence of carcinogenesis was reported in male rats treated with 2.5 and 4.1 mg/kg of body weight. In a second study, no carcinogenesis was observed in rats, males or females, treated with fluoride up to 11.3 mg/kg of body weight. Epidemiological data provide no credible evidence for an association between fluoride, either naturally occurring or added to drinking water, and risk of human cancer.
Fluoride ion is not mutagenic in standard bacterial systems. It has been shown that fluoride ion has potential to induce chromosome aberrations in cultured human and rodent cells at doses much higher than those to which humans are exposed. In vivo data are conflicting. Some studies report chromosome damage in rodents, while other studies using similar protocols report negative results.
Potential adverse reproductive effects of fluoride exposure in humans has not been adequately evaluated. Adverse effects on reproduction were reported for rats, mice, fox, and cattle exposed to 100 ppm or greater concentrations of fluoride in their diet or drinking water. Other studies conducted in rats demonstrated that lower concentrations of fluoride (5 mg/kg of body weight) did not result in impaired fertility and reproductive capabilities.
Pregnancy:
Pregnancy Category B. It has been shown that fluoride crosses the placenta of rats, but only 0.01% of the amount administered is incorporated in fetal tissue. Animal studies (rats, mice, rabbits) have shown that fluoride is not a teratogen. Maternal exposure to 12.2 mg fluoride/kg of body weight (rats) or 13.1 mg/kg of body weight (rabbits) did not affect the litter size or fetal weight and did not increase the frequency of skeletal or visceral malformations. There are no adequate and well-controlled studies in pregnant women. However, epidemiological studies conducted in areas with high levels of naturally fluoridated water showed no increase in birth defects. Heavy exposure to fluoride during in utero development may result in skeletal fluorosis, which becomes evident in childhood.
Nursing Mothers:
It is not known if fluoride is excreted in human milk. However, many drugs are excreted in milk, and caution should be exercised when products containing fluoride are administered to a nursing woman. Reduced milk production was reported in farm-raised fox when the animals were fed a diet containing a high concentration of fluoride (98-137 mg/kg of body weight). No adverse effects on parturition, lactation, or offspring were seen in rats administered fluoride up to 5 mg/kg of body weight.
Pediatric Use:
The use of DentaGel 1.1% Brush-On Gel in pediatric age groups 6 to 16 years as a caries preventive is supported by pioneering clinical studies with 1.1% sodium fluoride gels in mouth trays in students age 11-14 years conducted by Englander et al. 2,3, 4 Safety and effectiveness in pediatric patients below the age of 6 years have not been established. Please refer to the CONTRAINDICATIONS and WARNINGS sections.
ADVERSE REACTIONS:
OVERDOSAGE:
Accidental ingestion of large amounts of fluoride may result in acute burning in the mouth and sore tongue. Nausea, vomiting, and diarrhea may occur soon after ingestion (within 30 minutes) and are accompanied by salivation, hematemesis, and epigastric cramping abdominal pain. These symptoms may persist for 24 hours. If less than 5 mg fluoride/kg body weight (i.e., less than 2.3 mg fluoride/lb body weight) have been ingested, give calcium (e.g., milk) orally to relieve gastrointestinal symptoms and observe for a few hours. If more than 5 mg fluoride/kg body weight (i.e., more than 2.3 mg fluoride/lb body weight) have been ingested, induce vomiting, give orally soluble calcium (e.g., milk, 5% calcium gluconate or calcium lactate solution) and immediately seek medical assistance. For accidental ingestion of more than 15 mg fluoride/kg of body weight (i.e., more than 6.9 mg fluoride/lb body weight), induce vomiting and admit immediately to a hospital facility. A treatment dose (a thin ribbon) of DentaGel 1.1% Brush-On gel contains 2 mg fluoride. A 2 oz. tube contains 255 mg fluoride.
DOSAGE AND ADMINISTRATION:
Follow these instructions unless otherwise instructed by your dental professional:
- Adults and pediatric patients 6 years of age or older, apply a thin ribbon of gel to the teeth with a toothbrush or mouth trays once daily for at least one minute, preferably at bedtime.
- After use, adults expectorate gel. For best results, do not eat, drink, or rinse for 30 minutes. Pediatric patients, ages 6-16, expectorate gel after use and rinse mouth thoroughly.
SPL UNCLASSIFIED SECTION
REFERENCES:
- American Dental Association, Council on Dental Therapeutics, Fluoride compounds, In: Accepted Dental Therapeutics, Ed. 40, Chicago, ADA, 405-407 (1984).
- H.R. Englander et al., Clinical Anticaries Effect of Repeated Topical Sodium Fluoride Applications by Mouthpieces, JADA, 75, 638-644 (1967).
- H.R. Englander et al., Residual Anticaries Effect of Repeated Topical Sodium Fluoride Applications by Mouthpieces, JADA 78, 783-787 (1969).
- H.R. Englander et al., Incremental Rates of Dental Caries After Repeated Topical Sodium Fluoride Applications in Children with Lifelong Consumption of Fluoridated Water, JADA 82, 354-358 (1971).
SPL UNCLASSIFIED SECTION
PRINCIPAL DISPLAY PANEL - 56 g Tube
INGREDIENTS AND APPEARANCE
| DENTAGEL
sodium fluoride gel |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
| Labeler - Rising Pharmaceuticals, Inc. (041241766) |
| Registrant - Rising Pharmaceuticals, Inc. (041241766) |
| Establishment | |||
| Name | Address | ID/FEI | Business Operations |
|---|---|---|---|
| Sheffield Pharmaceuticals Div of Faria Limited LLC | 151177797 | MANUFACTURE(64980-307) | |